← Back to Search

Peer Coaching for Congenital Heart Disease (CHASM in ACHD Trial)

N/A
Waitlist Available
Led By Richard A Krasuski, MD
Research Sponsored by Duke University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-26
Diagnosis of congenital heart disease
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 10 years
Awards & highlights

CHASM in ACHD Trial Summary

This trial will test whether peer coaching can help young adults with congenital heart disease.

Who is the study for?
This trial is for young adults aged 18-26 with congenital heart disease who are patients at a Duke pediatric cardiology clinic and have access to a smartphone. It's not suitable for individuals with cognitive delays or those attending an adult cardiology clinic.Check my eligibility
What is being tested?
The study is looking into the effectiveness of peer health coaching as an intervention for young adults with congenital heart disease, aiming to improve their health outcomes and self-management skills.See study design
What are the potential side effects?
Since this trial involves peer coaching rather than medication, there aren't typical medical side effects. However, participants may experience emotional or psychological impacts from discussing their condition.

CHASM in ACHD Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 26 years old.
Select...
I was born with a heart condition.

CHASM in ACHD Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 10 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 10 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Determine change in patient activation
Determine change in self-management
Evaluate completion of study
+2 more
Secondary outcome measures
Determine change in emotional health
Determine change in health related quality of life
Determine change in transition readiness
+1 more

CHASM in ACHD Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Peer CoachingExperimental Treatment1 Intervention
Participant receive a 6 month peer health coaching intervention.
Group II: Education onlyActive Control1 Intervention
Participants receive education-only material (newsletter) biweekly for 6 months

Find a Location

Who is running the clinical trial?

Duke UniversityLead Sponsor
2,359 Previous Clinical Trials
3,420,189 Total Patients Enrolled
Adult Congenital Heart AssociationUNKNOWN
1 Previous Clinical Trials
50 Total Patients Enrolled
Richard A Krasuski, MDPrincipal InvestigatorDuke University
1 Previous Clinical Trials
27 Total Patients Enrolled

Media Library

Peer Health Coaching Clinical Trial Eligibility Overview. Trial Name: NCT04271358 — N/A
Congenital Heart Disease Research Study Groups: Education only, Peer Coaching
Congenital Heart Disease Clinical Trial 2023: Peer Health Coaching Highlights & Side Effects. Trial Name: NCT04271358 — N/A
Peer Health Coaching 2023 Treatment Timeline for Medical Study. Trial Name: NCT04271358 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are elderly individuals being sought for involvement in this trial?

"The trial is only open to individuals aged between 18 and 26. Separately, there are 95 studies for minors and 268 trials targeting seniors."

Answered by AI

Are there any opportunities for recruitment into this research project?

"Clinicaltrials.gov verifies that this clinical trial, which was initially posted on October 8th 2020 is presently recruiting participants. The most recent update to the study's information occurred on October 26th 2021."

Answered by AI

How many individuals have been accepted into this clinical investigation?

"Affirmative. The commencement date of this medical study is October 8th 2020, according to the clinicaltrials.gov repository, and it is presently recruiting 80 test subjects across one site."

Answered by AI

Are there any qualifications that must be met to partake in this trial?

"To be eligible for this clinical investigation, potential participants must have a diagnosis of congenital heart disease and fall between the age brackets of 18 to 26. A total of 80 enrollees are being accepted into the trial."

Answered by AI

What is the chief aim of this investigation?

"During this trial, assessors will track participants over the 3-month and 6-month intervals to evaluate the number of enrollees. Secondary parameters include gauging shifts in transition preparedness using TRAQ scores, changes in emotional health assessed with BSI metrics, and successful adult cardiology referrals which must be maintained for a decade post study."

Answered by AI
~7 spots leftby Apr 2025